Nirman Agri Genetics Complete Financial Statements

In FY2025, Nirman Agri Genetics (NIRMAN) reported revenue ₹237 Cr, net profit ₹25 Cr and EPS ₹31.57, with a net profit margin of 10.5% and ROE of 22.7%. Full financial statements from FY2021 to FY2025 (5 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see NIRMAN company profile.

5 Years of Data
2025 - 2021

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 10.55% 2025 data
EBITDA Margin 11.39% 2025 data
Operating Margin 11.00% 2025 data
Return on Assets 22.12% 2025 data
Return on Equity 22.73% 2025 data

Balance Sheet Ratios

Debt to Equity 1.03 2025 data
Equity Ratio 97.35% 2025 data
Asset Turnover 2.10 2025 data

NIRMAN Revenue, Net Profit & EBITDA — Year-on-Year Growth

NIRMAN YoY (March 2024 vs March 2025) — revenue +276.2%, net profit +150.0%, EBITDA +145.5%, expenses +303.8%.

Revenue Growth
+276.2%
Year-over-Year
Net Profit Growth
+150.0%
Year-over-Year
EBITDA Growth
+145.5%
Year-over-Year
Expense Growth
+303.8%
Year-over-Year
Assets Growth
+156.8%
Year-over-Year
Equity Growth
+197.3%
Year-over-Year
Liabilities Growth
+156.8%
Year-over-Year
Operating Cash Flow Growth
-900.0%
Year-over-Year
Investing Cash Flow Growth
+600.0%
Year-over-Year
Financing Cash Flow Growth
+4700.0%
Year-over-Year

NIRMAN Income Statement — Revenue, EBITDA & Net Profit

Nirman Agri Genetics revenue ₹237 Cr, EBITDA ₹27 Cr, net profit ₹25 Cr, EPS ₹31.57 (2025) — net profit margin 10.5%. Explore NIRMAN value investing to estimate fundamental worth using multiple valuation models.

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021
Revenue 237 63 29 14 4
Expenses 210 52 24 10 4
EBITDA 27 11 4 3 0
Operating Profit Margin % 11.00% 18.00% 15.00% 25.00% 2.00%
Depreciation 1 0 0 0 0
Interest 0 0 0 0 0
Profit Before Tax 26 11 4 3 0
Tax 1 1 0 1 0
Net Profit 25 10 4 3 0
Earnings Per Share (₹) 31.57 12.99 10.24 2560.20 54.70

NIRMAN Balance Sheet — Assets, Liabilities & Shareholders' Equity

NIRMAN total assets ₹113 Cr, total equity ₹110 Cr, total liabilities ₹113 Cr (2025) — ROE 22.7%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021
ASSETS
Total Assets 113 44 30 6 2
Current Assets 101 22 9 6 2
Fixed Assets 2 0 1 0 0
Capital Work in Progress 0 0 0 0 0
Investments 0 0 0 0 0
Other Assets 111 44 29 6 2
LIABILITIES
Total Liabilities 113 44 30 6 2
Current Liabilities 0 0 1 1 1
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 110 37 27 3 0
Share Capital 8 6 6 0 0
Reserves & Surplus 102 31 21 3 0

NIRMAN Cash Flow Statement — Operating, Investing & Financing

Nirman Agri Genetics operating cash flow ₹-32 Cr, investing ₹10 Cr, financing ₹46 Cr, net cash flow ₹24 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021
Operating Activities -32 4 0 0 0
Investing Activities 10 -2 -21 0 0
Financing Activities 46 -1 20 0 1
Net Cash Flow 24 1 -1 0 1